Healthy Skepticism Library

Items published during the years 1990 to 1999

There are 2138 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.

Page 22 of 22 pages ‹ First  < 20 21 22

HSL4097
Robinson WK.
A sample argument
Canadian Medical Association Journal 1990; 143:611

HSL4098
Rodwin MA.
Industrial marketing and medical ethics
New England Journal of Medicine 1990; 322:64

HSL4099
Roeg N.
The other drug trade
Adbusters 1990; 1:(4):80-87
www.adbusters.org/adbusters/

HSL4100
Russell R, Nelson PJ, Ohri L.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990; 322:64-65

HSL4103
Scherr L.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990; 113:408

HSL4109
Shepherd R.
Junk mail
Canadian Medical Association Journal 1990; 143:14

HSL4110
Shickman MD.
CME’s relationship with industry
Journal of Continuing Education in the Health Professions 1990; 10:189-190

HSL4111
Shulkin D.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990; 113:407

HSL4113
Solomon SD.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990; 322:65

HSL4114
Squires BP.
Editors and advertisers
Canadian Medical Association Journal 1990; 143:167

HSL4115
Squires BP.
PAAB: a lesson in self-government
Canadian Medical Association Journal 1990; 143:1151

HSL4116
Stein U.
Ginkgo biloba extracts
Lancet 1990; 335:475-476

HSL4118
Information or communication? A consumer study of television advertising
Taylor Nelson Research 1990;

HSL4119
Thomas M, Lexchin J.
Responsiveness to physicians' requests for information concerning drug interactions: a comparison of brand and generic companies.
Soc Sci Med 1990; 31:(2):153-7

HSL4122
Tilyard MW, Dovey SM.
Placement of advertisements
New Zealand Medical Journal 1990; 103:382

HSL4123
Timpany J.
A sample argument
Canadian Medical Association Journal 1990; 143:129

HSL4124
Tomson G, Angunawela I.
Patients, doctors and their drugs. A study at four levels of health care in an area of Sri Lanka
European Journal of Clinical Pharmacology 1990; 39:463-467

HSL4125
Tomson G, Weerasuriya K.
'Codes' and practice: information in drug advertisements--an example from Sri Lanka.
Soc Sci Med 1990; 31:(7):737-41

HSL4126
Van HR, Mazmanian PE, Osborne CE.
Commercial support for CME courses sponsored by medical schools
Journal of Continuing Education in the Health Professions 1990; 10:197-210

HSL4127
Venturelli J.
Medical ethics: a dilemma at our doorstep
Annals of the Royal College of Physicians and Surgeons of Canada 1990; 23:335

HSL4129
Williams AP, Cockerill R.
Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians
1990;

HSL4130
Williams EB.
Advertising acyclovir
Lancet 1990; 335:288

HSL4131
Zaini J.
Pushing children’s vitamins
HAI News 1990; (51):1-2, 11

HSL4136
Cohen EP.
Are pharmaceutical ads good medicine?
Business and Society Review 1990; 73:8-10

HSL4137
Secunda E.
Is TV addicted to drug company PR?
Business and Society Review 1990; 73:11-14

HSL4145
Hamer P.
More medication for healthy women!
DES Action Canada Newsletter 1990; (23):1-2
www.web.net/~desact

HSL9482
Halperin JA.
Strategic issues in the Rx-to-OTC switch
Drug Information Journal 1990; 24:(1):13-18

HSL9483
Schondelmeyer SW.
Economic aspects of switch
Drug Information Journal 1990; 24:(1):57-66

HSL9488
Mela S.
European communities: outstanding white paper proposals for the completion of internal market in the pharmaceutical sector
Drug Information Journal 1990; 24:(3):635-638

HSL9490
Monk MR, Smith M.
Product portfolio analysis: SmithKline to SmithKline Beecham
Journal of Pharmaceutical Marketing Management 1990; 4:(4):85-96

HSL19057
Schwartz LM, Woloshin S.
Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994.
Eff Clin Pract 1999; 2:(2):76-85.
http://www.acponline.org/clinical_information/journals_publications/ecp/marapr99/changing.htm

HSL19745
Ed.
Drug promotion: stealth, wealth, and safety.
Lancet 1993 12; 341:(8859):1507-8
http://www.sciencedirect.com/science/article/pii/014067369390637V

HSL19795
Huston P, Moher D.
Redundancy, disaggregation, and the integrity of medical research.
Lancet 1996 13; 347:(9007):1024-6
http://www.ncbi.nlm.nih.gov/pubmed/8606568

HSL19798
Wilmshurst P.
Publication bias.
Lancet 1991 8; 337:(8754):1419
http://www.sciencedirect.com/science/article/pii/014067369193110U

HSL19835
Brotzman GL, Mark DH.
The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.
J Gen Intern Med 1993; 8:(3):130-4
http://www.ncbi.nlm.nih.gov/pubmed/8455108

HSL19855
McNeil JJ, Grabsch EA, McDonald MM
Postmarketing surveillance: strengths and limitations.The flucloxacillin-dicloxacillin story.
Med J Aust. 1999 Mar 15; 170:(60):270-3
http://www.ncbi.nlm.nih.gov/pubmed/10212650

HSL19861
Stauber J, Rampton S
The Public Relations Industry's Secret War on Activists
Covert Action Quarterly 1995
http://mediafilter.org/caq/Caq55.prwar.html

HSL19862
Caudill TS, Johnson MS, Rich EC, McKinney WP.
Physicians, pharmaceutical sales representatives, and the cost of prescribing.
Arch Fam Med 1996; 5:(4):201-6
http://www.ncbi.nlm.nih.gov/pubmed/8769907

Page 22 of 22 pages ‹ First  < 20 21 22